Phase 0 With Expansion Phase Clinical Trial of Quisinostat Plus Radiotherapy in Newly-diagnosed and Recurrent Grade 4 IDH-Wildtype Glioblastomas
Clinical trial NCT06824662 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06824662
- Sponsor
- Nader Sanai
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-04
- Primary completion
- 2026-07-15
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.